Vesalius Therapeutics
Cambridge, United States· Est.
Vesalius Therapeutics is a biotechnology company developing novel small molecule therapies targeting tissue-specific biology to treat a range of diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $420M
About
Vesalius Therapeutics is a biotechnology company developing novel small molecule therapies targeting tissue-specific biology to treat a range of diseases.
Small MoleculesMetabolicCardiovascular
Funding History
4Total raised:$420M
Series D$105M
Series C$105M
Series B$105M
Series A$105M